Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49538
Title: High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy study
Authors: Marien , Joachim
VAN DIJCK, Christophe
Berens-Riha, Nicole
Willems, Elisabeth
Zaeck, Luca M.
Jones, Scott
Hicks, Bethany
Otter, Ashley
Yates, Jenifer L.
Hunt, Danielle T.
Lee, William T.
Bracke, Stefanie
Verschueren, Jacob
Vanroye, Fien
Bosman, Evi
De Cock, Natalie
Smekens, Bart
Vandenhove, Leen
Goovaerts, Odin
van Hul, Anke
Soentjens, Patrick
Marchant, Arnaud
Van Esbroeck, Marjan
Vercauteren, Koen
Adriaensen, Wim
de Vries, Rory D.
Arien, Kevin K.
Liesenborghs, Laurens
Issue Date: 2026
Publisher: ELSEVIER
Source: Lancet Microbe, 7 (5) (Art N° 101316)
Abstract: Background Mpox, caused by monkeypox virus (MPXV), has gained global attention following several international outbreaks. Accurate and high-throughput detection of MPXV-specific antibodies is essential for surveillance programmes, diagnosis, and vaccine trials. We therefore evaluated the long-term accuracy of an mpox multiplex immunoassay that measures IgG responses to 11 orthopoxvirus antigens. Methods The assay was validated in a diagnostic accuracy study involving a Belgian cohort of clade IIb MPXVinfected individuals (n=211) and modified vaccinia virus Ankara-Bavarian Nordic (MVA-BN) vaccine recipients (n=202), who were followed up for 2 years after exposure. We used receiver operating characteristic analysis to assess diagnostic performance at multiple timepoints after infection or vaccination compared with negative controls (n=287). To explore the assay's broader utility, we also investigated correlations between antigen-specific IgG responses and neutralising antibody titres. Findings In individuals without previous smallpox vaccination (n=149), the assay accurately detected mpox infection up to 2 years after infection, achieving 92% sensitivity (95% CI 89-97) at 95% specificity (91-98) when multiple antigens were combined. By contrast, diagnostic performance was low in previously vaccinated individuals (n=62), with sensitivities of most antigens dropping below 60% (38-77) after 6 months. Most antigen-specific IgG responses correlated strongly with neutralising antibody titres. Interpretation The assay shows high sensitivity and specificity for detecting previous mpox infection in unvaccinated individuals, with reliable performance up to 2 years after infection. Strong concordance with neutralising antibody titres supports the assay's potential for monitoring long-term infection and vaccine-induced immunity. However, previous vaccination status should be considered when interpreting results. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Notes: Marien, J (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
jmarien@itg.be
Document URI: http://hdl.handle.net/1942/49538
e-ISSN: 2666-5247
DOI: 10.1016/j.lanmic.2025.101316
ISI #: 001792526700001
Rights: 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
main.pdfPublished version410.75 kBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.